IVF Add-Ons: Scientific, Ethical, Regulatory, and Legal Considerations
Harvard University's Petrie-Flom Center is hosing a webinar on IVF add-ons on November 10, 2020 at noon EST. Dr. Gleicher is a panelist on the webinar. Follow along as Petrie-Flom Center live-Tweet the event [here](http://IVF Add-Ons: Scientific, Ethical, Regulatory, and Legal Considerations)!
Norbert Gleicher, MD, FACOG, FACS
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.
We have helped women bring over
17,800 babies into the world.
DISCOVER YOUR TREATMENT OPTIONS
You Might Also Enjoy...
For women trying to get pregnant after 40, CHR believes in an urgent and individualized treatment approach. Time is a very important factor with DOR, and the sooner treatment can be started, the higher a woman's pregnancy chances.
The Connection Between Obesity and Infertility
Infertility in women and men is widely recognized as a multifactorial condition in which, in many individuals, multiple factors may contribute to the diagnosis.
Am I a Candidate for Egg Donation?
Egg donation is a beneficial treatment that can assist women who can’t conceive with their eggs. Find out what goes into the egg donation process here.
The March/April Voice
Every issue of the VOICE slowly drifts towards more professional subjects, peaking with the literature review, which, primarily addresses physicians and scientists.
Evaluating Your Fertility: When Should You Seek Out a Second Opinion?
If you’re struggling with infertility, you might be wondering if your diagnosis is correct or if you have the right treatment plan. Take a moment to find out what a second opinion can do for you.
IVF in Alabama - What To Do Next?
CHR offers the safe transfer of existing frozen embryos into our facility, ensuring continuity of care for patients affected by the suspension of IVF services in Alabama.